Published
Capital Solutions is proud to collaborate with the medical physics team at Children’s Cancer Hospital 57357, supporting robust QA workflows while preparing for the launch of proton therapy.
CAIRO, EGYPT — Capital Solutions has reaffirmed its commitment to advancing pediatric oncology care through an ongoing technical partnership with the medical physics and clinical teams at Children’s Cancer Hospital Egypt (57357).
Recognized as a regional benchmark for pediatric cancer treatment, Hospital 57357 continues to drive clinical excellence by combining advanced technological infrastructure with rigorous quality assurance standards. Capital Solutions is actively collaborating with the hospital's physics department to optimize robust daily Quality Assurance (QA) workflows for state-of-the-art photon treatments.
Furthermore, this collaborative work serves as a foundational step as 57357 prepares for its next major technology milestone: the implementation and clinical integration of proton therapy. This partnership underlines a shared dedication to raising treatment precision and safety standards for pediatric cancer patients across the region.
Capital Solutions represented IBA Dosimetry at the IAEA conference in Luxor, leading practical sessions and sharing technical expertise on Patient-Specific Quality Assurance (PSQA).
Hosted IT-V Application Specialist Anja Munk to strengthen technical support and future collaboration in advanced radiotherapy fixation solutions.
